1.31BMarket Cap-567P/E (TTM)
26.300High24.470Low1.31MVolume25.250Open25.430Pre Close33.53MTurnover3.14%Turnover RatioLossP/E (Static)50.78MShares47.97052wk High-40.11P/B1.08BFloat Cap8.43052wk Low--Dividend TTM41.72MShs Float318.750Historical High--Div YieldTTM7.20%Amplitude2.650Historical Low25.618Avg Price1Lot Size
Spyre Therapeutics Stock Forum
U.S. stocks advanced on Monday, building off a record finish ahead of the ramping up of fourth-quarter earnings season.
The $Dow Jones Industrial Average(.DJI.US)$ rose 138 points, or 0.26%, to 38,000. The $S&P 500 Index(.SPX.US)$ was up 10 points, or 0.22%, at 4,850. The $Nasdaq Composite Index(.IXIC.US)$advanced 49 points, or 0.32%, to 15,360.
While the S&P 500 finally returned to record territory on Friday, skeptic...
Spyre felt the positive pressure from fresh buy ratings by analysts like Stifel. $Ginkgo Bioworks(DNA.US)$ also roase 9%, despite a new sell rating from Goldman Sachs.
But monday morning was not al...
No comment yet